These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 16792551

  • 1. Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy.
    Sakashita N, Ando Y, Haraoka K, Terazaki H, Yamashita T, Nakamura M, Takeya M.
    Pathol Int; 2006 Jul; 56(7):408-12. PubMed ID: 16792551
    [Abstract] [Full Text] [Related]

  • 2. Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience.
    Barreiros AP, Post F, Hoppe-Lotichius M, Linke RP, Vahl CF, Schäfers HJ, Galle PR, Otto G.
    Liver Transpl; 2010 Mar; 16(3):314-23. PubMed ID: 20209591
    [Abstract] [Full Text] [Related]

  • 3. Marked cardiomegaly in a patient with familial amyloidotic polyneuropathy after orthotopic liver transplantation: a case study.
    Sakashita N, Kagawa S, Date R, Ueno T, Nakagawa T, Yamashita T, Obayashi K, Ohshima T, Ueda M, Horiguchi H, Ando Y, Takeya M.
    Pathol Int; 2013 May; 63(5):260-5. PubMed ID: 23714253
    [Abstract] [Full Text] [Related]

  • 4. Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning?
    Lauro A, Diago Usò T, Masetti M, Di Benedetto F, Cautero N, De Ruvo N, Dazzi A, Quintini C, Begliomini B, Siniscalchi A, Ramacciato G, Risaliti A, Miller CM, Pinna AD.
    Transplant Proc; 2005 Jun; 37(5):2214-20. PubMed ID: 15964382
    [Abstract] [Full Text] [Related]

  • 5. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y.
    Transplantation; 2004 Feb 15; 77(3):345-9. PubMed ID: 14966406
    [Abstract] [Full Text] [Related]

  • 6. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients.
    Oguchi K, Takei Y, Ikeda S.
    Amyloid; 2006 Jun 15; 13(2):99-107. PubMed ID: 16911964
    [Abstract] [Full Text] [Related]

  • 7. Combined heart and liver transplantation for familial amyloidotic neuropathy.
    Pilato E, Dell'Amore A, Botta L, Arpesella G.
    Eur J Cardiothorac Surg; 2007 Jul 15; 32(1):180-2. PubMed ID: 17449267
    [Abstract] [Full Text] [Related]

  • 8. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.
    Herlenius G, Wilczek HE, Larsson M, Ericzon BG, Familial Amyloidotic Polyneuropathy World Transplant Registry.
    Transplantation; 2004 Jan 15; 77(1):64-71. PubMed ID: 14724437
    [Abstract] [Full Text] [Related]

  • 9. Finding of vascular amyloid TTR in inferior nasal concha in a patient with FAP TTRVal30Met.
    Munar-Ques M, Martinez-Nadal J, Torres-Rovira JJ, Sole M, Zabay-Becerril JM, Mulet-Ferrer JM.
    Amyloid; 2008 Dec 15; 15(4):272-4. PubMed ID: 19065300
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outcome of liver transplantation for familial amyloidotic polyneuropathy.
    Sharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, Douglas DD, Mulligan DC, Rakela J, Wiesner RH, Balan V.
    Liver Transpl; 2003 Dec 15; 9(12):1273-80. PubMed ID: 14625827
    [Abstract] [Full Text] [Related]

  • 12. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
    Suhr OB.
    Amyloid; 2003 Aug 15; 10 Suppl 1():77-83. PubMed ID: 14640045
    [Abstract] [Full Text] [Related]

  • 13. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
    Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, Baba S, Kametani F, Ikeda S.
    Biochem Biophys Res Commun; 2000 Aug 11; 274(3):702-6. PubMed ID: 10924339
    [Abstract] [Full Text] [Related]

  • 14. [A sporadic case of late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) inborn habitant of Ehime prefecture].
    Harada T, Ishizaki F, Togo M, Yamashita H, Nitta K, Date Y, Nakazato M, Yamamura Y, Nakamura S.
    No To Shinkei; 2002 Jul 11; 54(7):615-9. PubMed ID: 12187722
    [Abstract] [Full Text] [Related]

  • 15. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant.
    García-Herola A, Prieto M, Pascual S, Berenguer M, López-Viedma B, Mir J, Vilchez JJ, Berenguer J.
    Liver Transpl Surg; 1999 May 11; 5(3):246-8. PubMed ID: 10226117
    [Abstract] [Full Text] [Related]

  • 16. Transthyretin-related familial amyloidotic polyneuropathy.
    Ando Y, Nakamura M, Araki S.
    Arch Neurol; 2005 Jul 11; 62(7):1057-62. PubMed ID: 16009758
    [Abstract] [Full Text] [Related]

  • 17. Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report.
    Muller KR, Padbury R, Jeffrey GP, Poplawski NK, Thompson P, Tonkin A, Harley HA.
    Liver Transpl; 2010 Apr 11; 16(4):470-3. PubMed ID: 20373457
    [Abstract] [Full Text] [Related]

  • 18. Combined heart and liver transplantation for familial amyloidotic neuropathy: considerations from the hepatic point of view.
    Grazi GL, Cescon M, Salvi F, Ercolani G, Ravaioli M, Arpesella G, Magelli C, Grigioni F, Cavallari A.
    Liver Transpl; 2003 Sep 11; 9(9):986-92. PubMed ID: 12942463
    [Abstract] [Full Text] [Related]

  • 19. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C.
    Kawaji T, Ando Y, Nakamura M, Yamashita T, Wakita M, Ando E, Hirata A, Tanihara H.
    Ophthalmology; 2005 Dec 11; 112(12):2212. PubMed ID: 16225929
    [Abstract] [Full Text] [Related]

  • 20. [Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial].
    Ando Y.
    Rinsho Byori; 2000 May 11; 48(5):425-9. PubMed ID: 10892290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.